NSE › Healthcare

Alkem Laboratories Limited (ALKEM)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹5,707.00-0.77%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹3,603 cr
Revenue YoY
+14.6%
Net profit
₹236 cr
Profit YoY
-22.7%
EPS
₹26.50
EPS estimate
₹39.25
Net margin
6.6%

EPS came in at 26.50 against a street estimate of 39.25 — a miss of 32.5%.

Key statistics

Market cap
₹68,571 cr
P/E
29.8
Forward P/E
33.8
P/B
4.98
Book value
₹1,155.87
EPS (TTM)
₹192.68
Dividend yield
0.91%
52-week high
₹5,915.00
52-week low
₹4,700.61
50-day MA
₹5,491.02
200-day MA
₹5,543.16
Beta
0.27

Analyst view

with an average price target of ₹5,964.80.

Shareholding

Promoters
62.91%
Institutions
25.10%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alkem Laboratories Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.